Encora Therapeutics expands VA access to essential tremor wearable
Encora Therapeutics has announced that its FDA-cleared Encora X1 wearable is available for order through the U.S. Department of Veterans Affairs (VA), expanding access for veterans with essential tremor. The prescription-only wrist-worn device uses non-invasive mechanical neurostimulation to help manage hand tremors without medication or surgery. In a sham-controlled clinical study, 70%–75% of participants achieved a one-point improvement in tremor-related disability after 30 minutes of stimulation, compared with 48% in the sham group. The device can be used independently or alongside existing treatments to support everyday activities such as eating, writing, and holding objects.
Mibro launches AeroPace smartwatch with AI-powered running coaching
Mibro has launched AeroPace, its first running smartwatch designed for beginner runners, combining AI-powered personalized training plans with real-time performance insights through the Mibro Coach feature. Weighing 32 g, the device features an AMOLED display, dual-band five-satellite positioning, and multi-channel optical heart rate monitoring. Available through Mibro’s official channels from October 13, 2026, AeroPace starts at €149.99 and aims to make structured, data-driven running training more accessible.
Hims & Hers launches Hers in Australia for personalized women’s healthcare
Hims & Hers has launched its Hers brand in Australia, rebranding Juniper, the women’s health platform acquired through Eucalyptus, to expand personalized digital care for women. The platform offers clinician-supported programs for hair regrowth, menopause and perimenopause, and weight management, alongside nutrition and fitness support and 24/7 Care Team access. The launch completes the company’s broader Australian brand rollout following Pilot’s transition to Hims in August 2026, strengthening its presence in the country’s telehealth market.
